+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-03-25Number of Pages: 73

Vitreous Tamponades Market (Tamponades Types: Gaseous Tamponades and Liquid Tamponades [Silicone Oil, Perfluorocarbons]) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Global Vitreous Tamponades Market: Snapshot

The global vitreous tamponades market is envisioned to be encouraged by a high demand arising from the need to replace disintegrated vitreous humor in aging patients with a synthetic alternative that could act as a retinal reattachment medium. Vitreous tamponade is researched to be an ideal synthetic substitute for vitreous humor which disintegrates with age, eventually leading to retinal detachment or tear. Moreover, vitreous tamponade could aid the healing process.

As per a latest study, the global vitreous tamponades market could be valued at a US$77.5 bn by 2020.

Remarkable Effectiveness in Retinal Tear Treatment Earns Strong Demand for Liquid Tamponades

Industry players looking to make an impact on the world vitreous tamponades market could take to exploring business opportunities in different segments by type of tamponade. Different markets by type roof different prospects, which need to be determined with a keen eye and leveraged at the right time for maximum profit. According to tamponade type segmentation, the market could witness the rise of liquid and gaseous products.

However, the liquid tamponades market is anticipated to account for a colossal share in future in terms of revenue, as it had secured in the recent past. Owing to their high degree of effectiveness in treating retinal tear, liquid tamponades are expected to showcase their dominance in the market. Rest of the World, Europe, and Asia Pacific could be key geographical markets for liquid tamponades.

Contrastingly, gaseous tamponades are predicted to exhibit a faster growth in comparison with liquid tamponades for the coming years. This could be due to the ease of use and low cost of gaseous tamponades. As foreseen by seasoned analysts, the liquid tamponades market could be further categorized into perfluorocarbons and silicone oil. Amongst the two, silicone oil had registered a massive share in the world vitreous tamponades market in the past. The relatively slower growth of perfluorocarbons could be blamed on their limited usage. They are employed during the execution of treatments for giant retinal tear or break (GRT) as an intraoperative tool.

North America Takes Control of Telling Share with Premium Prices of Tamponades

Despite the widespread application of liquid tamponades in the aforementioned key geographies, North America is prognosticated to catch hold of a significant share in the international vitreous tamponades market. Even in the present scenario, it boasts of a leading share in the market. Followed by Europe, the region could score an over 30.0% share to dominate other players in the market until 2020.

One of the major factors foretold to drive the growth of North America is the telling awareness about vitreoretinal diseases. Premium-priced tamponades could be another reason for the supremacy of North America over other regions deemed important for the market. Furthermore, the region could rest its hopes on the mounting occurrence of retinal detachment and age-related macular degeneration.

Asia Pacific, on the flipside, is prophesied to record a higher CAGR during the course of the forecast period 2014–2020. Some of the chief aspects of growth that could take shape in Asia Pacific include the surging count of tamponade manufacturers. Besides this, Southeast Asia and countries such as India and China holding a significant presence of diabetics or a larger diabetic population are envisaged to be another powerful factor contributing toward the growth of Asia Pacific in the international vitreous tamponades market.

Few of the leading companies operating in the worldwide vitreous tamponades market could be Fluoron GmbH, Dutch Ophthalmic Research Center B.V., Carl Zeiss Meditec AG, Valeant Pharmaceuticals International, Inc., and Alcon, Inc.

 
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
     1.3.1 Secondary Research
     1.3.2 Primary Research
1.4 Assumptions
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Vitreous Tamponades Market (2013 & 2020)
2.2 Global Vitreous Tamponades Market Revenue, by Types, 2013 (USD Million)
2.3 Comparative Analysis: Global Vitreous Tamponades Market Revenue, by Geography, 2013 & 2020 (Value %)
 
Chapter 3 Market Overview
3.1 Introduction
3.2 Market Drivers
     3.2.1 Increasing incidence of retinal detachment, macular pucker and other disorders
     3.2.2 Rise in geriatric population that is at higher risk of developing retinal disorders
3.3 Market Restraints
     3.3.1 Commoditization of the vitreous tamponades industry in Europe, Asia Pacific and RoW
     3.3.2 Decline in diabetic retinopathy cases in North America
3.4 Market Opportunities
     3.4.1 Strong research and development activities to develop vitreous tamponades provide a good platform to record high growth
3.5 Value Chain Analysis
3.6 Porters Five Forces Analysis: Global Vitreous Tamponades Market
     3.6.1 Bargaining power of suppliers
     3.6.2 Bargaining power of buyers
     3.6.3 Threat of new entrants
     3.6.4 Threat of substitutes
     3.6.5 Competitive rivalry
3.7 Market Attractiveness Analysis of the Global Vitreous Tamponades Market, by Geography, 2013
3.8 Heat Map analysis
     3.8.1 Heat Map Analysis for Vitreous Tamponades Market, by Key Market Players and Regional Presence
 
Chapter 4 Vitreous Tamponades Market, by Types
4.1 Overview
     4.1.1 Global Vitreous Tamponades Market Revenue, by Types, 2012 – 2020 (USD Million)
     4.1.2 Global Vitreous Tamponades Market Volume, by Types, 2012 – 2020 (No. of Units)
4.2 Average Pricing Analysis
4.3 Gaseous Tamponades
     4.3.1.1 Global Gaseous Tamponades Market Revenue, 2012 – 2020 (USD Million)
     4.3.1.2 Global Gaseous Tamponades Market Volume, 2012 – 2020 (No of Units)
4.4 Liquid Tamponades
     4.4.1 Global Liquid Tamponades Market Revenue, 2012 – 2020 (USD Million)
             4.4.1.1 Global Liquid Tamponades Market Volume, 2012 – 2020 (No of Units)
     4.4.2 Silicone Oil
             4.4.2.1 Global Silicone Oil Market Revenue, 2012 – 2020 (USD Million)
     4.4.3 Perfluorocarbon Liquids (PFCL)
             4.4.3.1 Global Perfluorocarbon Liquids Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 5 Vitreous Tamponades  Market, by Geography
5.1 Overview
     5.1.1 Global Vitreous Tamponades Market Revenue, by Geography, 2012 – 2020 (USD Million)
5.2 North America
     5.2.1 North America Vitreous Tamponades Market Revenue, by Types, 2012 – 2020 (USD Million)
5.3 Europe
     5.3.1 Europe Vitreous Tamponades Market Revenue, by Types, 2012 – 2020 (USD Million)
5.4 Asia Pacific
     5.4.1 Asia Pacific Vitreous Tamponades Market Revenue, by Types, 2012 – 2020 (USD Million)
5.5 Rest of the World
     5.5.1 RoW Vitreous Tamponades Market Revenue 2012 – 2020 (USD Million)
 
Chapter 6 Recommendations
6.1 Market Strategy for Success
     6.1.1 Focus on innovation of vitrectomy equipment and tamponade materials to improve-post surgical outcomes
     6.1.2 Focus on emerging markets
     6.1.3 Organizing awareness campaigns to expand their geographic presence
 
Chapter 7 Company Profiles
7.1 AL.CHI.MI.A Srl
     7.1.1 Company Overview
     7.1.2 Financial Overview
     7.1.3 Product Portfolio
     7.1.4 Recent Developments
7.2 Alcon, Inc.
     7.2.1 Company Overview
     7.2.2 Financial Overview
     7.2.3 Product Portfolio
     7.2.4 Business Strategies
     7.2.5 Recent Developments
7.3 Valeant Pharmaceuticals International Inc.
     7.3.1 Company Overview
     7.3.2 Financial Overview
     7.3.3 Product Portfolio
     7.3.4 Business Strategies
     7.3.5 Recent Developments
7.4 Carl Zeiss Meditec AG
     7.4.1 Company Overview
     7.4.2 Financial Overview
     7.4.3 Product Portfolio
     7.4.4 Business Strategies
     7.4.5 Recent Developments
7.5 CROMA-PHARMA GmbH
     7.5.1 Company Overview
     7.5.2 Financial Overview
     7.5.3 Product Portfolio
     7.5.4 Business Strategy
     7.5.5 Recent Developments
7.6 Dutch Ophthalmic Research Center (International) B.V.
     7.6.1 Company Profile
     7.6.2 Financial Overview
     7.6.3 Product Portfolio
     7.6.4 Business Strategies
     7.6.5 Recent Developments
7.7 Fluoron GmbH
     7.7.1 Company Overview
     7.7.2 Financial Overview
     7.7.3 Product Portfolio
     7.7.4 Business Strategy
     7.7.5 Recent Developments

List of Figures
 
FIG. 1 Vitreous Tamponades: Market Segmentation
FIG. 2 Global Vitreous Tamponades Market Revenue, by Types, 2013 (USD Million)
FIG. 3 Comparative Analysis: Global Vitreous Tamponades Market Revenue, by Geography, 2013 & 2020 (Value %)
FIG. 4 Global Vitreous Tamponades Market, Value Chain Analysis
FIG. 5 Porter’s Five Forces Analysis: Global Vitreous Tamponades Market
FIG. 6 Market Attractiveness Analysis: Global Vitreous Tamponades Market, by Geography
FIG. 7 Heat Map Analysis for Vitreous Tamponades Market by Key Market Players
FIG. 8 Global Gaseous Tamponades Market Revenue, 2012 - 2020 (USD Million)
FIG. 9 Global Gaseous Tamponades Market Volume, 2012 - 2020 (No. of Units)
FIG. 10 Global Liquid Tamponades Market Volume, 2012 - 2020 (No. of Units)
FIG. 11 Global Silicone Oil Market Revenue, 2012 - 2020 (USD Million)
FIG. 12 Global Perfluorocarbon Liquids Market Revenue, 2012 - 2020 (USD Million)
FIG. 13 Alcon, Inc. (Surgical Division): Annual Revenue, 2011 - 2013 (USD Million)
FIG. 14 Valeant Pharmaceuticals International Inc.: Annual Revenue, 2011 - 2013 (USD Million)
FIG. 15 Carl Zeiss Meditec, AG.: Annual Revenue, 2011 – 2013 (USD Million)

List of Tables
 
TABLE 1 Market Snapshot: Global Vitreous Tamponades (2013 & 2020)
TABLE 2 Global Vitreous Tamponades Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 3 Global Vitreous Tamponades Market Volume, by Types, 2012 – 2020 (No. of Units)
TABLE 4 Global Liquid Tamponades Market Revenue, 2012 – 2020 (USD Million)
TABLE 5 Global Vitreous Tamponades Market Revenue, by Geography, 2012 – 2020 (USD Million)
TABLE 6 North America Vitreous Tamponades Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 7 Europe Vitreous Tamponades Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 8 Asia Pacific Vitreous Tamponades Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 9 RoW Vitreous Tamponades Market Revenue 2012 – 2020 (USD Million)

 
Vitreous tamponades are essentials used in vitrectomy procedures conducted in the human eye that either assist in healing/reattachment of the retina or provide a replacement to a clouded vitreous humor. This report studies the current as well as future prospects of the global vitreous tamponades market. The report comprises an elaborate executive summary that includes extensive analysis of the vitreous tamponade products and their market based on applicability, effectiveness, sales revenue and geographic presence. In addition, the executive summary includes a market snapshot, which comprises market trends and dynamics of various market segments that are included in this report. The executive summary chapter also includes a waterfall diagram that reflects the market size of various segments for the year 2013.
 
The market overview section of the report comprises analysis of the vitreous tamponades market by considering factors that determine the market dynamics such as drivers, restraints and opportunities. This section of the report also includes Porter’s five forces analysis that covers the global market in terms of bargaining power of buyers and suppliers, threat of new entrants and substitutes, and competitive rivalry. In addition, the section comprises market attractiveness analysis that helps gain knowledge about the most attractive and leading geographic region in the global vitreous tamponades market. The market overview section also includes market share analysis of the key players (in terms of value %) operating in the vitreous tamponades market for the year 2013, and value chain analysis that studies major steps involved in the preparation and distribution of vitreous tamponades by manufacturers. 
 
Based on types, the vitreous tamponades market has been segmented into gaseous tamponades and liquid tamponades. The liquid tamponades segment has been further sub-segmented into silicone oil and perfluorocarbon liquids. The gaseous tamponades segment on the other hand includes market revenue of SF6 and C3F8 collectively. The market for these two types of vitreous tamponades has been extensively analyzed based on factors such as sales revenues, usage pattern, developments and geographic presence. The market size and forecast in terms of revenue (USD million) for each of these types have been provided for the period from 2012 to 2020, considering 2013 as the base year. The report also provides the compound annual growth rate (CAGR) for each segment for the forecast period from 2014 to 2020.
 
Geographically, the vitreous tamponades market has been segmented into four major regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). Each geographical region has been further segmented, based on types of tamponades, into gaseous tamponades and liquid tamponades. The market size and forecast for each of these regions have been provided for the period from 2012 to 2020, along with CAGR (%) for the forecast period from 2014 to 2020. The research study also incorporates the competitive scenario in these regions.
 
The report also provides a heat map analysis of the major players in the vitreous tamponades market have been included. A list of recommendations has been provided for new entrants as well as existing players to help establish a strong presence in the market and increase market shares. The report concludes with profiles of major players in the vitreous tamponades market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players profiled in this report include Alcon, Inc., Valeant Pharmaceuticals International, Inc. (parent of Bausch + Lomb), Carl Zeiss Meditec AG, Dutch Ophthalmic Research Center B.V., Fluoron GmbH, Croma - Pharma AG, and AL.CHI.MI.A Srl.
 
The global vitreous tamponades market is segmented as follows:
 
Global Vitreous Tamponades Market Revenue, by Types
  • Gaseous Tamponades 
  • Liquid Tamponades
    • Silicone Oil
    • Perfluorocarbons
Global Vitreous Tamponades Market Revenue, by Geography
  • North America
    • Gaseous Tamponades
    • Liquid Tamponades
  • Europe
    • Gaseous Tamponades
    • Liquid Tamponades
  • Asia Pacific
    • Gaseous Tamponades
    • Liquid Tamponades
  • RoW
    • Gaseous Tamponades
    • Liquid Tamponades


 
 
Back To Top